Description

2,6-Methano-3-Benzazocine,6,11-Diethyl-1,2,3,4,5,6-Hexahydro-,(2Alpha,6Alpha,11S*)-(9Ci) is a complex, stereochemically defined benzazocine derivative, a class of compounds known for their significant potential in advanced pharmaceutical research and development. This compound matters as a sophisticated chemical building block or pharmacological reference standard for creating novel therapeutic agents, particularly in the central nervous system (CNS) domain. It is primarily needed by research institutions, pharmaceutical R&D laboratories, and fine chemical manufacturers focused on developing new analgesics, neuropharmacological agents, or other specialized bioactive molecules.

Application

• Pharmaceutical Intermediate: Serves as a key chiral precursor in the multi-step synthesis of novel opioid receptor ligands or other CNS-targeting drug candidates.
• Medicinal Chemistry Research: Used as a core scaffold for structure-activity relationship (SAR) studies to explore new biological activities and optimize drug-like properties.
• Reference Standard: Acts as a high-purity analytical standard for method development, quality control, and regulatory submissions in drug discovery pipelines.
• Biochemical Tool Compound: Employed in vitro and in vivo studies to investigate specific receptor interactions and signal transduction pathways related to pain modulation.
• Academic Research: Utilized in university and institutional labs for advanced studies in organic synthesis, asymmetric catalysis, and heterocyclic chemistry.
• Contract Research & Manufacturing (CRAM): Supplied to organizations offering custom synthesis and process development services for the pharmaceutical industry.

Basic Information

Item	Details
Product Name	2,6-Methano-3-Benzazocine,6,11-Diethyl-1,2,3,4,5,6-Hexahydro-,(2Alpha,6Alpha,11S*)-(9Ci)
CAS No.	736087-78-8
Molecular Formula	Contact for details
Molecular Weight	Contact for details
Synonyms	6,11-Diethyl-1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocine; (2α,6α,11S*)-6,11-Diethyl-1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocine; Benzazocine derivative 736087-78-8; 2,6-Methano-3-benzazocine, 6,11-diethyl-1,2,3,4,5,6-hexahydro-, (2α,6α,11S*)-; 9CI Index Name; Potential opioid scaffold; Stereoisomeric benzazocine.
EINECS	Contact for details

Quality Control

Our 2,6-Methano-3-Benzazocine derivative is produced under strict quality management protocols. Each batch undergoes rigorous analytical testing, including HPLC for purity and chiral analysis to confirm stereochemical integrity, ensuring it meets the exacting standards required for research and development. Certificates of Analysis (COA) with detailed chromatographic data are available upon request to support your regulatory and quality assurance needs.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at a controlled room temperature (typically 15-25°C). As a complex organic compound, it should be handled under an inert atmosphere if specified and kept away from strong oxidizing agents.

Specification

Item	Specification
Appearance	White to off-white solid
Identification (IR)	Conforms to structure
Purity (HPLC)	≥ 97.0%
Chiral Purity	≥ 98.0% ee
Water Content (KF)	≤ 0.5%
Residue on Ignition	≤ 0.1%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.